TY - JOUR UR - https://doi.org/10.25259/JCIS-9-6 DO - 10.25259/JCIS-9-6 TI - A Case of Ferumoxytol (Feraheme®) Prompting Critical Modification to Our Patient Prebreast Magnetic Resonance Imaging Questionnaire AU - Samreen,Naziya AU - Bhatt,Asha A AU - Glockner,James AU - Lee,Christine U AB - Apparent gadolinium-based contrast enhancement was seen on precontrast-enhanced images on two breast magnetic resonance imaging (MRI) for a patient done 1 week apart. This was caused by ferumoxytol, which is used to treat some anemias. Such nongadolinium-based therapeutics exhibiting unintended MRI contrast-like properties preclude assessment of enhancement kinetics in breast MRI significantly limiting diagnostic interpretation. This case prompted a group discussion and subsequent modification to the patient breast MRI safety screening questionnaire at our institution. VL - 9 SP - 6 T2 - Journal of Clinical Imaging Science JO - Journal of Clinical Imaging Science J2 - Journal of Clinical Imaging Science SN - 2156-7514 SN - 2156-5597 ER -